-+ 0.00%
-+ 0.00%
-+ 0.00%

PURPLE BIOTECH REPORTS POSITIVE FINAL RESULTS FROM RANDOMIZED PHASE 2 STUDY OF CM24 IN SECOND LINE PANCREATIC CANCER

Reuters·12/02/2024 12:00:03

Please log in to view news